Enlarge / Heather Bresch, chief executive officer of drugmaker Mylan Inc.Getty | Bloomberg reader comments 13 Share this story On Tuesday, New York Attorney General Eric Schneiderman announced that his office is investigating Mylan Pharmaceuticals Inc, the maker of EpiPen, for potentially using anticompetitive terms in contracts it had with many school...